News

JOURNAL ARTICLES & PRESENTATIONS 

NYXOL® 

Phentolamine Mesylate Ophthalmic Solution Reduces Time to Recovery of Medically-Induced Mydriasis in a Phase 2 Trial – Presented at the  Association for Research in Vision and Ophthalmology (Online Video Presentation)
May 2020

Phentolamine Mesylate Ophthalmic Solution Provides Long Lasting Pupil Modulation and Improves Visual Acuity – Presented at the  Association for Research in Vision and Ophthalmology (Online Video Presentation)
May 2020

Ocuphire Pharma – Innovation Showcase – Presented at the Southeastern Educational Congress of Optometry – Ophthalmology Innovation Summit (Atlanta)
March 2020

Ocuphire Pharma – Innovation Showcase – Presented at the American Society of Cataract and Refractive Surgery – Ophthalmology Innovation Summit (San Diego)
May 2019

Phentolamine Mesylate Ophthalmic Solution Once Daily Reduces Pupil Diameter and Improves Night Vision Disturbances – Presented at the American Association of Ophthalmology Meeting (Chicago)
October 2018

Phentolamine Mesylate Treatment of Severe Night Vision Complaints – Presented at the American Association of Ophthalmology Meeting (Chicago)
October 2010